<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF MD2PATIENT INC. FOR THE SIX MONTHS ENDED JUNE 30, 2000
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                       1,395,836
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,505,729
<PP&E>                                         530,664
<DEPRECIATION>                                  60,000
<TOTAL-ASSETS>                               5,042,663
<CURRENT-LIABILITIES>                        4,531,000
<BONDS>                                              0
                                0
                                     50,000
<COMMON>                                       177,000
<OTHER-SE>                                    (318,867)
<TOTAL-LIABILITY-AND-EQUITY>                 5,042,663
<SALES>                                         88,000
<TOTAL-REVENUES>                                88,000
<CGS>                                                0
<TOTAL-COSTS>                                4,470,435
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               5,000
<INCOME-PRETAX>                             (4,354,485)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (4,354,485)
<EPS-BASIC>                                      (0.18)
<EPS-DILUTED>                                    (0.18)


</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission